Trial Profile
A study evaluating safety and efficacy of Vonoprazan based therapy as first and second line eradication therapy versus lansoprazole based therapy for Helicobacter pylori infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2017
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Metronidazole (Primary) ; Vonoprazan (Primary) ; Lansoprazole
- Indications Helicobacter pylori infections
- Focus Adverse reactions; Therapeutic Use
- 06 Jan 2017 New trial record